MTTP and gastrointestinal disease: These nanovesicles target microsomal triglyceride transfer protein (MTP) and angiopoietin-like protein-4 (ANGPTL 4) in the mitochondria, which are therapeutic targets for reducing plasma lipids and inflammation in gastrointestinal diseases caused by obesity [99].